This afternoon, both Chardan Healthcare (CHACU) and CF Finance (CFFAU) filed amended S-1s, indicating they are getting ready to price next week. Chardan Healthcare’s S-1/A consisted mostly of nits and clarifying their underwriting fees regarding the $100,000 to be paid to B. Riley FBR as Qualified Independent Underwriter, so there were no material changes. Additionally, there were no material changes for CF Finance either for that matter.
These two amendments come on the heels of Schultze Special Purpose (SAMAU) also filing their amended S-1 yesterday. So, pricing is shaping up to look like the following:
- Monday, Dec. 10th: $150 million, Schultze Special Purpose Acquisition Corp. (for trading Tuesday)
- Wednesday, December 12th: $250 million, CF Finance Acquisition Corp. (for trading Thursday)
- Thursday, December 13th: $70 million, Chardan Healthcare Acquisition Corp. (for trading Friday)
As for the two Cowen-led deals – Monocle Acquisition Corp. (MNCLU) and Andina Acquisition Corp. III (ANDAU), these will now be Q-1 2019 deals. This means we should end the year at 46 SPACs with total gross proceeds (before over-allotments) of $10.739 billion.
It’s going to be a busy week and most likely the last “busy” week of the year….enjoy the weekend.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...